supplements
Silent Churn and Contamination Risks in the US Supplement Industry
67% of supplement customers churn silently at Day 45, raising concerns about contamination risks amid limited FDA oversight in the $60 billion industry.
supplements
supplements
The Protocol Gap: Why Supplements Lack the Rigor of Pharmaceuticals
Discover the protocol gap between pharmaceuticals and supplements, emphasizing the $60 billion trust deficit and its implications for consumers.
pharmaceuticals
What Pharmaceuticals Got Right That Supplements Got Wrong: The Case for Protocols
This article examines how rigorous protocols in pharmaceuticals highlight the shortcomings of the supplement industry and proposes a self-study protocol for readers.
supplements
Silent churn hits 67% of supplement users by day 45, costing brands $40-80 CAC
A new audit finds 67% of supplement subscribers quit by day 45, but brands see no early warning, costing $40‑$80 CAC per lost user.
supplements
Why 90% of Supplement Protocols Fail Without Evidence Layers—and How Data Saves Money
A 2025 case study reveals that adding an evidence layer to supplement routines reduces churn by 2.8 times. Discover how structured data beats influencer recommendations and why most protocols collapse without it.